Home/Bliss GVS Pharma/Ketan V. Shah
KV

Ketan V. Shah

Chief Financial Officer

Bliss GVS Pharma

Bliss GVS Pharma Pipeline

DrugIndicationPhase
Anti-malarial Portfolio (ACTs)MalariaApproved
Anti-infectives PortfolioBacterial & Fungal InfectionsApproved
Pain Management ProductsPain & InflammationApproved
Gastrointestinal ProductsGI DisordersApproved
New Generic Filings (e.g., for US/EU)VariousRegulatory Review